Interval breast cancer diagnosed within 1–12 months

Disease

4 findings

“Compared to 24 m IBC, 12 m IBC was associated with higher odds of axillary lymph node metastases”
Clinical Characteristics of Interval Breast Cancer Diagnosed Within 12 Months of a Normal Screening Mammogram Compared with Those Diagnosed Between 13-24 Months in UtahJournal of breast imaging2026doi:10.1093/jbi/wbag036

Associations

4

Extremely dense breast tissue

upin humans1OR 2.05

1 study
  1. Interval breast cancer diagnosed within 1–12 months are associated with extremely dense breast tissue in humans (compared with interval breast cancer diagnosed at 13–24 months) (OR 2.05, 95% CI 1.13–3.80).

    Humanscompared with interval breast cancer diagnosed at 13–24 monthsbreastfemalesn = 2,122

Triple-negative breast cancer

upin humans1OR 2.08

1 study
  1. Interval breast cancer diagnosed within 1–12 months are associated with triple-negative breast cancer in humans (compared with interval breast cancer diagnosed at 13–24 months) (OR 2.08, 95% CI 1.26–3.39).

    Humanscompared with interval breast cancer diagnosed at 13–24 monthsbreastfemalesn = 2,122

More on Triple-negative breast cancer

HER2-positive breast cancer

upin humans1OR 2.1

1 study
  1. Interval breast cancer diagnosed within 1–12 months are associated with HER2-positive breast cancer in humans (compared with interval breast cancer diagnosed at 13–24 months) (OR 2.10, 95% CI 1.36–3.22).

    Humanscompared with interval breast cancer diagnosed at 13–24 monthsbreastfemalesn = 2,122

More on HER2-positive breast cancer

Axillary lymph node metastases

upin humans1OR 1.68

1 study
  1. Interval breast cancer diagnosed within 1–12 months are associated with axillary lymph node metastases in humans (compared with interval breast cancer diagnosed at 13–24 months) (OR 1.68, 95% CI 1.29–2.19).

    Humanscompared with interval breast cancer diagnosed at 13–24 monthsaxillary lymph nodefemalesn = 2,122

More on Axillary lymph node metastases